Albumin turnover in renal disease

Mineral and Electrolyte Metabolism

Volumn 24, Issue 1, 1997, Pages 55-63

  Kaysen, George A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute phase response; Albumin catabolism; Albumin distribution; Continuous ambulatory peritoneal dialysis; Dialysis; Fractional catabolic rate; Hypoalbuminemia; Ibumin synthesis; Nephrotic syndrome

Indexed keywords

ALBUMIN;

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HYPOALBUMINEMIA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOSING GASTROENTEROPATHY; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW;

ALBUMINURIA; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; NEPHROTIC SYNDROME; PROTEIN-LOSING ENTEROPATHIES; SERUM ALBUMIN;

EID: 12644278313     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057351     Document Type: Review

References (93)

1. Earley LE, Farland M: Nephrotic syndrome; in Strauss MB, Welt LG (eds): Diseases of the Kidney. Boston, Little, Brown, 1979, pp 765-813.
2. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
3. Kaysen GA, Watson JB: Mechanism of hypoalbuminemia in the 7/8 nephrectomized rat with chronic renal failure. Am J Physiol 1982; 243:F372-F378.
4. Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984;25: 107-114.
5. Lowrie EG, Lew NL, Huang WH: Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int 1992;38(suppl):S22-S31.
6. Sellers AL, Katz J, Bonorris G, Okyyama S: Determination of extravascular albumin in the rat. J Lab Clin Med 1966;68:177-185.
7. Reeve EB, Chen AY: Regulation of interstitial albumin; in Rothschild MA, Waldmann T (eds): Plasma Protein Metabolism: Regulation of Synthesis, Distribution, and Degradation. New York, Academic Press, 1970, pp 89-109.
8. Rothschild MA, Oratz M, Evans CD, Schreiber SS: Albumin synthesis; in Rosemoer M, Oratz M, Rothschild A (eds): Albumin Structure, Function and Uses. New York, Pergamon, 1977, pp 227-255.
9. Waldmann TA: Albumin catabolism; in Rosemoer M, Oratz M, Rothschild A (eds): Albumion Structure, Function and Uses. New York, Pergamon, 1977, pp 255-273.
10. Yedgar S, Carew TE, Pittman RC, Beltz WF: Tissue sites of catabolism of albumin in rabbits. Am J Physiol 1983;244:E101-E107.
11. Baynes JW, Thorpe SR: Identification of sites of albumin catabolism in the rat. Arch Biochem Biophys 1981;206:372-379.
12. James WP, Hay AM: Albumin metabolism: Effect of the nutritional state and the dietary protein intake. J Clin Invest 1968;47:1958-1972.
13. Morgan EH, Peters T Jr: The biosynthesis of rat serum albumin. J Biol Chem 1971;246: 3500-3507.
14. Kirsch R, Frith L, Black E, Hoffenberg R: Regulation of albumin synthesis and catabolism by alteration of dietary protein. Nature 1968;217: 578-579.
15. Hoffenberg R, Black E, Brock JF: Albumin and gamma-globulin tracer studies in protein depletion states. J Clin Invest 1966;45:143-152.
16. Yap SH, Strair RK, Shafritz DA: Effect of a short term fast on the distribution of cytoplasmic albumin messenger ribonucleic acid in rat liver. J Biol Chem 1978;253:4944-4950.
17. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH: Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987; 79:1635-1641.
18. Koj A, Gauldie J, Sweeney GD, Regoeczi E, Sauder DN: A simple bioassay for monocyte-derived hepatocyte stimulating factor: Increased synthesis of α2-macroglobulin and reduced synthesis of albumin by cultured rat hepatocytes. J Immunol Methods 1985;76: 317-327.
19. Bauer J, Weber W, Tran-Thi T, Northoff G, Decker K, Gerok W, Heinrich PC: Murine interleukin 1 stimulates α2-macroglobulin synthesis in rat hepatocyte primary cultures. FEES Lett 1985;190:271-274.
20. Jamieson JC, Kaplan HA, Woloski BMNJ, Hellman M, Ham K: Glycoprotein biosynthesis during the acute-phase response to inflammation. Can J Biochem Cell Biol 1983;61: 1041-1048.
21. Koj A, Gauldie J, Regoecsi E, Sauder DN, Sweeney GD: The acute-phase response of cultured rat hepatocytes. Biochem J 1984;224: 505-514.
22. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR: Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986;78:1349-1355.
23. 1 acid glycoprotein RNA during inflammation. J Biol Chem 1987;262:12826-12831.
24. Guo-Fen T, De Jong F, Apostolopoulos J, Nagashima M, Fidge N, Schreiber G, Hewlett G: Effect of acute inflammation on rat apolipoprotein mRNA levels. Inflammation 1987;11: 241-251.
25. Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R, Avram DK, Chattopadhyay J: Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study. Periton Dial Int 1996;16(suppl 1):S190-S194.
26. Kaysen GA, Rathore V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
27. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Schen GH, Gandi VC, Tucker CT, Curtis FK, Coburn JW: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980; 33:1567-1585.
28. Schoenfeld PY, Henry RR, Laird NM, Roxe DM: Assessment of nutritional status of the National Cooperative Dialysis Study population. Kidney Int 1983;23(suppl 13):80-88.
29. Acchiardo SR, Moore LW, Latour AP: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983;24(suppl 16):S199-S203.
30. Kopple J, Shinaberger J, Coburn J, Sorensen M, Rubini M: Optimal dietary protein treatment during chronic hemodialysis. ASAIO Trans 1989;15:302-308.
31. Bergström J: Why are dialysis patients malnourished? Am J Kidney Dis 1995;26:229-241.
32. Bergström J: Anorexia in dialysis patients. Semin Nephrol 1996;16:222-229.
33. Yang CS, Chen SW, Chiang CH, Wang M, Peng SJ, Kan YT: Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients. Am J Kidney Dis 1996;27: 380-386.
34. Ikizler TA, Wingard RL, Hakim RM: Interventions to treat malnutrition in dialysis patients: The role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 1995;26:256-265.
35. Phillips ME, Havard J, Howard JP: Oral essential amino acid supplementation in patients in maintenance hemodialysis. Clin Nephrol 1978; 9:241-248.
36. Hecking E, Kohler H, Zobel R, Lamellel EM, Mader H, Opferkuch W, Prellwitz W, Keim HF, Muller D: Treatment with essential amino acids in patients on chronic hemodialysis: A double blind crossover study. Am J Clin Nutr 1987;31:1821-1826.
37. Compher C, Mullen J, Barker C: Nutritional support in renal failure. Surg Clin North Am 1991;71:597-608.
38. Wolfson M: Use of nutritional supplements in dialysis patients. Semin Dial 1992;5:285-290.
39. Wolfson M, Foulks CJ: Intradialytic parenteral nutrition: A useful therapy? Nutr Clin Pract 1996;11:5-11.
40. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Tores MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 1994;23: 808-816.
41. Bergström J, Heimbürger O, Lindholm B, Qureshi AR: Elevated serum CRP is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients (abstract). J Am Soc Nephrol 1995;6:573.
42. Kaysen GA, Rathore V, Depner TA: C reactive protein (CRP) and serum amyloid A (SAA) levels predict serum albumin levels (Salb) in hemodialysis (HD) patients. J Am Soc Nephrol 1996;7:1486.
43. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990; 37:116-125.
44. Docci D, Bilancioni R, Baldrati L, Capponcini C, Turci F, Feletti C: Elevated acute phase reactants in hemodialysis patients. Clin Nephrol 1990;34:88-91.
45. Trznadel K, Luciak M, Paradowski M, Kubasiewicz-Ujma B: Hemodialysis and the acute-phase response in chronic uremic patients. Int J Artif Organs 1989;12:762-765.
46. Bologa RM, Levine DM, Parker TS, Serur D, Stenzel KH, Rubin A, Cheigh JS: High cytokine levels may mediate the high mortality of hemodialysis (HD) patients with low albumin and/or cholesterol (TC) (abstract). J Am Soc Nephrol 1995;6:573.
47. Han DS, Lee SW, Kang SW, Choi KH, Lee YH, Cho EY, Lee JO: Factors affecting low values of serum albumin in CAPD patients. Adv Periton Dial 1996;12:288-292.
48. Canivet E, Lavaud S, Wong T, Guenounou M, Willemin JC, Potron G, Chanard J: Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis 1994;23:41-46.
49. Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP: C5b-9 generation and cylokine production in hemodialyzed patients. Kidney Int 1993;41:S221-S225.
50. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994;331:1338-1342.
51. Memoli B, Libetta C, Rampino T, De Simone W, Meccariello S, Slangherlin P, Dal Canton A, Andreucci VE: Interleukin-6 production of uraemic haemodialysed patients: Effects of different membranes. Nephrol Dial Transplant 1991;6(suppl 2):96-98.
52. Zaoui P, Hakim RM: The effects of the dialysis membrane on cytokine release. J Am Soc Nephrol 1994;4:1711-1718.
53. Chollet-Martin S, Slamalakis G, Bailly S, Mery JP, Gougerot-Pocidalo MA: Induction of tumor necrosis factor-alpha during haemodialysis: Influence of the membrane type. Clin Exp Immunol 1991;83:329-332.
54. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995;47:573-578.
55. Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CP, Meri S: Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron 1991;57:283-287.
56. Memoli B, Libetta C, Rampino T, Dal Canton A, Conte G, Scala G, Ruocco MR, Andreucci VE: Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992;42:320-326.
57. Donati D, Degiannis D, Combates N, Raskova J, Raska K Jr: Effects of hemodialysis on activation of lymphocytes: Analysis by an in vitro dialysis model. J Am Soc Nephrol 1992;2: 1490-1497.
58. Macdonald C, Rush DN, Bernstein KN, McKenna RM: Production of tumor necrosis factor alpha and hemodialysis. Nephron 1993; 65:273-277.
59. Haubitz M, Schulze M, Koch KM: Increase of CRP serum values following haemodialysis. Nephrol Dial Transplant 1990;5:500-503.
60. Pomianek MJ, Colton CK, Dinarello CA, Miller LC: Synthesis of tumor necrosis factor α and interleukin-1 receptor antagonist, but not interleukin-1 by human mononuclear cells is enhanced by exposure of whole blood to shear stress. ASAIO J 1996;42:52-59.
61. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-837.
62. Aukland K, Nicolaysen G: Interstitial fluid volume: Local regulatory mechanisms. Phys Rev 1981;61:556-643.
63. Guyton AC, Taylor AE, Granger HJ (eds): Circulatory Physiology II: Dynamics and Control of Body Fluids. Philadelphia, Saunders, 1975, pp 149-165.
64. Taylor AE: Capillary fluid filtration Starling forces and lymph flow. Circ Res 1981;49:557-575.
65. Kaysen GA, Gambertoglio J, Jiminez I, Jones H, Hutchison FN: Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986;29:572-577.
66. Kaysen GA, Kirkpatrick WG, Couser WG: Albumin homeostasis in the nephrotic rat: Nutritional considerations Am J Physiol 1984;247: F192-F202.
67. Jensen H, Rossing N, Anderson SB, Jarnum S: Albumin metabolism in the nephrotic syndrome in adults. Clin Sci 1967;33:445-457.
68. Katz J, Bonorris G, Sellers AL: Albumin metabolism in aminonucleoside nephrotic rats. J Lab Clin Med 1963;62:910-934.
69. Yedgar S, Carew TE, Pittman RC, Beltz WF: Tissue sites of catabolism of albumin in rabbits. Am J Physiol 1983;244:E101-E107.
70. Galaske RG, Baldamus CA, Stolte H: Plasma protein handling in the rat kidney: Micropuncture experiments in the acute heterologous phase of anti-gbm-nephritis. Pfluegers Arch 1978;375:269-277.
71. Katz J, Sellers AL, Bonorris G: Effect of nephrectomy on plasma albumin catabolism in experimental nephrosis. J Lab Clin Med 1964; 63:680-686.
72. Landwehr DM, Carvalho JS, Oken DE: Micropuncture studies of the filtration and absorption of albumin by nephrotic rats. Kidney Int 1977;11:9-17.
73. Lewy JE, Pesce A: Micropuncture study of albumin transfer in aminonucleoside nephrosis in the rat. Pediatr Res 1973;7:553-559.
74. Oken DE, Cotes SC, Mende CW: Micropuncture study of tubular transport of albumin in rats with aminonucleoside nephrosis. Kidney Int 1972;1:3-11.
75. Blainey JD: High protein diets in the treatment of the nephrotic syndrome Clin Sci 1954;13: 567-581.
76. Keutmann EH, Bassett SH: Dietary protein in hemorrhagic Bright's disease. II: The effect of diet on serum proteins, proteinuria and tissue proteins. J Clin Invest 1935;14:871-888.
77. Peters JP, Bulger HA: The relation of albuminuria to protein requirement in nephritis. Arch Intern Med 1926;37:153-185.
78. Rosenberg ME, Swanson JE, Thomas BL, Hostetter TH: Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol 1987;253:F1083-1090.
79. Kaysen GA, Jones H Jr, Martin V, Hutchison FN: A low protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 1989;83: 1623-1629.
80. Hutchison FN, Schambelan M, Kaysen GA: Modulation of albuminuria by dietary protein and converting enzyme inhibition. Am J Physiol 1987;253:F719-F725.
81. Choi EJ, Bailey J, May RC, Masud T, Maroni BJ: Metabolic responses to nephrosis: Effect of a low-protein diet. Am J Physiol 1994;266: F432-F438.
82. Kaysen GA, Rosenthal C, Hutchison FN: GFR increases before renal mass or ODC activity increase in rats fed high protein diets. Kidney Int 1989;36:441-446.
83. Hutchison FN, Martin V, Jones H Jr, Kaysen GA: Differing actions of dietary protein and enalapril on renal function and proteinuria. Am J Physiol 1990;258:F126-F132.
84. Sunheimer RL, Finck C, Mortazavi S, McMahon C, Pincus MR: Primary lupus-associated protein-losing enteropathy. Ann Clin Lab Sci 1994;24:239-242.
85. Chung U, Oka M, Nakagawa Y, Nishishita T, Sekine N, Tanaka Y, Harada S, Igarashi T, Ogata E: A patient with protein-losing enteropathy associated with systemic lupus erythematosus. Intern Med 1992;31:521-524.
86. Tanaka T, Damiao AO, Gabriel A Jr, Missi SM, Rodrigues CJ, Nobre MR, Sipahi AM, Yoshinari NH: Protein-losing enteropathy in systemic lupus erythematosus. Rev Hosp Clin Fac Med Univ Sao Paulo, 1991;46:34-37.
87. Kashihara T, Fujimori E, Oki A, Itoh T, Hashimoto K, Kotani K, Fukuda H, Tako H, Kawakami F, Okuno G, Nakatsuka H: Protein-losing enteropathy and pancreatic involvement in a case of connective tissue disease. Gastroenterol Jpn 1992;27:246-251.
88. Sunheimer RL, Finck C, Mortazavi S, McMahon C, Pincus MR: Primary lupus-associated protein-losing enteropathy. Ann Clin Lab Sci 1994;24:239-242.
89. Kawaguchi M, Koizumi F, Shimao M, Hirose S: Protein-losing enteropathy due to secondary amyloidosis of the gastrointestinal tract. Acta Pathol Jpn 1993;43:333-339.
90. Laine L, Garcia F, McGilligan K, Malinko A, Sinatra FR, Thomas DW: Protein-losing enteropathy and hypoalbuminemia in AIDS. AIDS 1993;7:837-840.
91. Perednia DA, Curosh NA: Lupus-associated protein-losing enteropathy. Arch Intern Med 1990;150:1806-1810.
92. Bhatnagar A, Lahoti D, Singh AK, Shankar LR, Sharma B, Singh T: Scintigraphic diagnosis of protein losing enteropathy using Tc-99m dextran. Clin Nucl Med 1995;20:1070-1073.
93. Bhatnagar A, Kashyap R, Chauhan UP, Mishra P, Chopra MK, Khanna CM: Diagnosing protein losing enteropathy: A new approach using Tc-99m human immunoglobulin. Clin Nucl Med 1995;20:969-972.